161 related articles for article (PubMed ID: 26642698)
1. Status of External Quality Assessment on Tumor Markers in China.
Xiao Y; Zhang C; Zhao H; Wang W; He F; Zhong K; Yuan S; Wang Z
Clin Lab; 2015; 61(10):1383-90. PubMed ID: 26642698
[TBL] [Abstract][Full Text] [Related]
2. [National external quality assessment and comparability of assays for tumor markers measurements].
Zhang JT; Zhang CB; Ma R; Zhao HJ; Wang J; Wang ZG; Chen WX
Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(14):993-7. PubMed ID: 20646652
[TBL] [Abstract][Full Text] [Related]
3. Investigating the Current Harmonization Status of Tumor Markers Using Global External Quality Assessment Programs: A Feasibility Study.
van Rossum HH; Holdenrieder S; Ballieux BEPB; Badrick TC; Yun YM; Zhang C; Patel D; Thelen M; Song J; Wojtalewicz N; Unsworth N; Vesper HW; Cui W; Ramanathan LV; Sturgeon C; Meng QH
Clin Chem; 2024 Apr; 70(4):669-679. PubMed ID: 38385453
[TBL] [Abstract][Full Text] [Related]
4. Tumor markers in serum and ascites in the diagnosis of benign and malignant ascites.
Zhu FL; Ling AS; Wei Q; Ma J; Lu G
Asian Pac J Cancer Prev; 2015; 16(2):719-22. PubMed ID: 25684514
[TBL] [Abstract][Full Text] [Related]
5. External Quality Assessment Program for Newborn Screening of Acylcarnitine in China, 2018.
He F; Wang W; Yuan S; Du Y; Zhong K; Wang Z
Clin Lab; 2019 Jun; 65(6):. PubMed ID: 31232035
[TBL] [Abstract][Full Text] [Related]
6. Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.
Dolscheid-Pommerich RC; Keyver-Paik M; Hecking T; Kuhn W; Hartmann G; Stoffel-Wagner B; Holdenrieder S
Tumour Biol; 2017 Oct; 39(10):1010428317730246. PubMed ID: 29034816
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of tumor markers for the differential diagnosis of benign and malignant ascites.
Liu F; Kong X; Dou Q; Ye J; Xu D; Shang H; Xu K; Song Y
Ann Hepatol; 2014; 13(3):357-63. PubMed ID: 24756011
[TBL] [Abstract][Full Text] [Related]
8. Comparison of immunoassays for tumor markers CA 19-9, CA 15-3 and CA 125: data from an international quality assessment scheme.
Pilo A; Zucchelli GC; Cohen R; Bizollon CA; Cappelli G; Cianetti A; Gion M; Piffanelli A; Bombardieri E
Tumori; 1995; 81(2):117-24. PubMed ID: 7539965
[TBL] [Abstract][Full Text] [Related]
9. CEA, AFP, CA125, CA153 and CA199 in malignant pleural effusions predict the cause.
Wang XF; Wu YH; Wang MS; Wang YS
Asian Pac J Cancer Prev; 2014; 15(1):363-8. PubMed ID: 24528057
[TBL] [Abstract][Full Text] [Related]
10. The reference intervals for CA125, CA15-3, CA19-9, CA72-4, AFP, CEA, NSE and CYFRA21-1.
Yang J; Tang A; Ma J; Sun X; Ming L
Scand J Clin Lab Invest; 2019; 79(1-2):71-74. PubMed ID: 30727773
[TBL] [Abstract][Full Text] [Related]
11. Interlaboratory surveys of the determination of tumour markers scatter and repeatability of the results.
Kruse R; Geilenkeuser WJ; Röhle G
Eur J Clin Chem Clin Biochem; 1993 Mar; 31(3):139-46. PubMed ID: 7683915
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Accuracy of Combinations of Tumor Markers for Malignant Pleural Effusion: An Updated Meta-Analysis.
Yang Y; Liu YL; Shi HZ
Respiration; 2017; 94(1):62-69. PubMed ID: 28427079
[TBL] [Abstract][Full Text] [Related]
13. Application of Six Sigma for evaluating the analytical quality of tumor marker assays.
Liu Q; Fu M; Yang F; Liang W; Yang C; Zhu W; Ma L; Zhao C
J Clin Lab Anal; 2019 Feb; 33(2):e22682. PubMed ID: 30280434
[TBL] [Abstract][Full Text] [Related]
14. Influence of cardiopulmonary resuscitation on levels of tumour markers.
Berent R; Auer J; Porodko M; Lamm G; Weber T; Wimmer E; Seier J; Aspöck G; Eber B
Eur J Cancer Care (Engl); 2006 Jul; 15(3):252-6. PubMed ID: 16882121
[TBL] [Abstract][Full Text] [Related]
15. A 3-year-long investigation of the authenticity of the return results of hepatitis B virus qualitative testing in external quality assessment in East China.
Song C; Shan Z; Kang F; Li W
J Med Virol; 2019 Jun; 91(6):1076-1080. PubMed ID: 30761566
[TBL] [Abstract][Full Text] [Related]
16. Standardization of tumor markers - priorities identified through external quality assessment.
Sturgeon C
Scand J Clin Lab Invest Suppl; 2016; 245():S94-9. PubMed ID: 27542005
[TBL] [Abstract][Full Text] [Related]
17. An immunohistochemical study of hepatic atypical adenomatous hyperplasia, hepatocellular carcinoma, and cholangiocarcinoma with alpha-fetoprotein, carcinoembryonic antigen, CA19-9, epithelial membrane antigen, and cytokeratins 18 and 19.
Tsuji M; Kashihara T; Terada N; Mori H
Pathol Int; 1999 Apr; 49(4):310-7. PubMed ID: 10365850
[TBL] [Abstract][Full Text] [Related]
18. Proficiency testing of maternal serum prenatal screening in second trimester in China, 2015.
Zhang X; Wang W; He F; Zhong K; Yuan S; Wang Z
Biochem Med (Zagreb); 2017 Feb; 27(1):114-121. PubMed ID: 28392734
[TBL] [Abstract][Full Text] [Related]
19. Prognostic values of normal preoperative serum cancer markers for gastric cancer.
Feng F; Sun L; Liu Z; Liu S; Zheng G; Xu G; Guo M; Lian X; Fan D; Zhang H
Oncotarget; 2016 Sep; 7(36):58459-58469. PubMed ID: 27533455
[TBL] [Abstract][Full Text] [Related]
20. External Quality Assessment Program for Newborn Screening of Amino Acids in China.
He F; Wang W; Yu C; Zhong K; Yuan S; Du Y; Wang Z
Clin Lab; 2019 Mar; 65(3):. PubMed ID: 30868847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
